Supervised vs Non-Supervised Incentive Spirometry After CABG (NCT07343921) | Clinical Trial Compass
CompletedNot Applicable
Supervised vs Non-Supervised Incentive Spirometry After CABG
Indonesia38 participantsStarted 2024-07-01
Plain-language summary
This study aims to evaluate the effect of supervised incentive spirometry (SIS) compared to unsupervised incentive spirometry (Non-SIS) on pulmonary function in patients following coronary artery bypass graft (CABG) surgery. Participants perform incentive spirometry exercises twice daily for three days after extubation. Pulmonary function parameters, including forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF), are assessed before and after the intervention period to compare changes between the two groups.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients aged ≥18 years.
* Patients who have undergone Coronary Artery Bypass Graft (CABG) surgery.
* Mechanical ventilation \<24 hours post-surgery.
* Physically able to perform incentive spirometry (IS) exercises.
* Signed informed consent to participate in the study.
Exclusion Criteria:
* Hemodynamically unstable patients.
* Patients with cognitive or communication impairments.
* Oral abnormalities that prevent the use of IS.
* Patients with Chronic Obstructive Pulmonary Disease (COPD).
* Patients with thoracic anomalies.
* Patients who required reintubation.
* History of incentive spirometry use within the last 3 months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Forced Expiratory Volume in 1 Second (FEV1)
Timeframe: T1 (24 hours post-extubation) and T2 (after 3 days of incentive spirometry exercise)